Zhongnan Medical Journal Press

Home Results

A total of 5 result was found. Results that relate to WANG Mei

Signal mining of adverse drug reaction related to MET-TKIs after marketing based on FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):300-310.
10462 times 1518 times

WANG Meisa HAN Qiushuang GAO Liang JIANG Yuan CHEN Zhe

Mesenchymal-epithelial transition factor tyrosine kinase inhibitors Food and Drug Administration Adverse Event Reporting System Adverse event signal mining Disproportionality analysis Pharmacovigilance
Details
Pharmacoeconomic evaluation of ribociclib plus fulvestrant in second-line treatment of HR+/HER2- advanced breast cancer for postmenopausal women

Published on Chinese Journal of Pharmacoepidemiology 2025,34(6):612-620.
9954 times 1574 times

JIA Caifeng WANG Jie ZHANG Sen WANG Meiqi LI Sainan WANG Mingxia

Ribociclib Fulvestrant Advanced breast cancer Postmenopausal Pharmacoeconomic evaluation Cost-effectiveness analysis
Details
Challenges and system construction of reproductive medicine ethics education

Published on Journal of Mathematical Medicine 2026,39(1):68-74.
2434 times 621 times

FAN Qigang KANG Jiawei ZHANG Yuanzhen WANG Mei

Reproductive medicine Medical ethics Ethical education Artificial intelligence Clinical practice
Details
Correlation between epidemiological characteristics and meteorological factors in critically ill patients with respiratory failure

Published on New Medicine 2026,36(1):8-14.
3960 times 619 times

MIAO Dong WANG Li'ao ZHANG Lei WANG Meiying YE Xiaolei TIAN Yingping HOU Yunsheng

Respiratory failure Epidemiology Seasonal variation Meteorological factors
Details
Adverse event signal mining and analysis of tucatinib based on the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(4):649-656.
849 times 188 times

ZHAO Jun ZHAO Zhenying WANG Meisa LI Weiya JIANG Yuan YANG Fengkun

Tucatinib Breast cancer HER2 inhibitor FAERS database Adverse event Disproportionality method
Details